Use of fibroin/hyaluronic acid matrices as a drug reservoir in iontophoretic transdermal delivery by Kuduğ, Emre
 Use of Fibroin/Hyaluronic Acid Matrices as a Drug 
Reservoir in Iontophoretic Transdermal Delivery 
 
By 
Emre KUDUĞ 
 
A Dissertation Submitted to the 
Graduate School in partial Fulfillment of the 
 Requirement for the Degree of 
 
MASTER OF SCIENCE 
 
 
Department: Chemical Engineering 
Major: Chemical Engineering 
 
 
İzmir Institute of Technology 
İzmir, Turkey 
 
 
February, 2004 
 
 
 
 
ACKNOWLEDGMENTS 
 
 I would like to acknowledge the guidance and support of my thesis advisor Asst. 
Prof. Ayşegül Batıgün and co-advisor Asst. Prof. Oğuz Bayraktar.  I am grateful to 
Prof. Devrim Balköse for providing the peristaltic pump used in this study. 
 
I would like to acknowledge the support of IYTE research fund (Project code 
AR-FON 017),  Iomed, Inc. (Utah, USA) for donation of the iontophoresis power 
supply, and Bursa Institute for Silkworm Research for providing raw silk. 
 
I would like to thank my colleague Özge Malay, my dearest friend Yelda Ergün 
and my dear friend Beyhan Cansever for their support and help in the experiments and 
also in the writing of this thesis. 
 iii
  
ABSTRACT 
 
Transdermal drug delivery is gaining importance due to the extensive research 
in genetics and resulting increase of protein and peptide based drugs in the market.   In 
order to develop materials to be used in iontophoretic transdermal drug delivery 
systems, various forms of silk fibroin (SF) and blending agents as hyaluronic acid (HA) 
have been tested for their feasibility as a potential drug reservoir.  For this purpose 
different forms of silk such as raw silk, degummed silk fibroin, insolubilized freeze-
dried fibroin, membranes of fibroin in pure and blended with HA were investigated for 
their adsorption capacities of timolol maleate, which is used as the model drug.  It was 
found that silk fibroin and derivatives have considerable adsorption capacities for 
timolol maleate with 0.35 mmol per gram, comparable with commercial membranes.  
The insolubilization of the membranes was required for drug loading and delivery in 
aqueous media.  Membrane insolubility was achieved by post treatment, manipulation 
of drying conditions, and blending with different agents.  Configurational changes of 
fibroin protein and interactions between silk fibroin and hyaluronic acid were 
investigated by Fourier transform infrared spectroscopy, scanning electron microscopy, 
and X-ray diffraction analyses.  Insoluble fibroin glutaraldehyde membranes were 
produced.  The obtained insoluble membranes were investigated for drug delivery 
performance in a custom-made diffusion cell under passive diffusion and iontophoretic 
conditions.  It was demonstrated that the silk fibroin glutaraldehyde films could be 
successfully used for controlled drug delivery.  It was found that current densities of 1.5 
and 3 mA/cm2 were suitable to accomplish controlled delivery of the drug in a pulsatile 
manner.  The results of this study are expected to be useful in controlled transdermal 
delivery of positively charged drug molecules. 
 
 iv
ÖZ 
 
Genetik bilimindeki kapsamlı araştırmalar ve bunun sonucu olarak protein ve 
peptit içerikli ilaçların piyasadaki miktarının artmasıyla  deri yoluyla ilaç iletimi önem 
kazanmaktadır.  İyontoforetik deri yoluyla ilaç iletim sistemleri geliştirmek amacıyla 
ipek fibroininin çeşitli formlarının ve hyaluronik asit ile karıştırılmış fibroinin 
potansiyel ilaç deposu olarak kullanılabilirlikleri test edilmiştir.  Bu amaçla ipeğin pek 
çok formunun, örneğin ham ipek, pişirilmiş ipek fibroini, dondurulup kurutularak 
çözünmeyen hale getirilmiş fibroin, saf ve hyaluronik asit ile karıştırılmış fibroin 
membranlarının model ilaç olarak kullanılan timolol maleat`ı adsorplama kapasiteleri 
incelenmiştir.  İpek fibroin ve türevlerinin ticari membranlarla kıyaslanabilir ve kayda 
değer düzeyde timolol maleat adsorpsiyon kapasitelerine sahip oldukları saptanmıştır.  
Sulu ortamda ilaç yüklenmesi ve iletimi için membranların çözünmez olması 
gerekmektedir.  Membranın çözünmezliği sonradan işleme metodları, kurutma 
koşullarının ayarlanması ve farklı kimyasallarla karıştırma suretiyle sağlanmıştır.  
Fibroin proteinin şekilsel değişiklikleri ve ipek fibroini ile hyaluronik asit arasındaki 
etkileşim Fourier transform kızılötesi spektroskopisi, taramalı elektron mikroskobu ve 
X-ışını kırınımı analizleriyle incelenmiştir.  Çözünmeyen fibroin glutaraldehit 
membranları ve metanol ile işlenmiş fibroin membranları üretilmiştir.  Elde edilen 
çözünmez membranların pasif difüzyon ve iyontoforetik koşullar altında ilaç iletim 
performansları özel yapım difüzyon hücresi kullanılarak incelenmiştir.  İpek fibroin 
glutaraldehit ve metanol ile işlenmiş fibroin filmlerin kontrollü ilaç iletimi için 
başarıyla kullanılabileceği gösterilmiştir. İlacın darbeli tarzda kontrollü iletimi 
başarılmıştır.  
 v
 TABLE OF CONTENTS 
LIST OF FIGURES ...................................................................................................... viii 
LIST OF TABLES............................................................................................................x 
Chapter 1 INTRODUCTION ........................................................................................1 
Chapter 2 TRANSDERMAL DRUG DELIVERY .......................................................3 
2.1. Controlled Drug Delivery .................................................................................3 
2.2. Methods of Transdermal Delivery....................................................................4 
2.2.1. Passive Diffusion ..........................................................................................4 
2.2.2. Phonophoresis...............................................................................................5 
2.2.3. Electroporation..............................................................................................5 
2.2.4. Iontophoresis.................................................................................................5 
2.2.5. Selection of Electrodes .................................................................................8 
Chapter 3 DRUG RESERVOIR MATRIX: PREPARATION OF INSOLUBLE 
SILK MATRIX.................................................................................................................9 
3.1. Silk Fibroin .......................................................................................................9 
3.2. Methods of Silk Fibroin Matrix Preparation...................................................13 
3.3. Previous Studies with Silk Fibroin .................................................................17 
3.3.1. SFGTA Blends............................................................................................17 
3.3.2. Freeze-Dried SF..........................................................................................18 
3.3.3. SF Film with Glutaraldehyde......................................................................18 
3.3.4. Other Studies with Silk Fibroin ..................................................................19 
3.4. Hyaluronic Acid..............................................................................................19 
3.5. Previous Studies with Hyaluronic Acid..........................................................21 
3.6. Insoluble Matrix Preparation ..........................................................................23 
3.7. Preparation of Silk Fibroin/Hyaluronic Acid Solution ...................................24 
Chapter 4 LOADING AND DELIVERY OF MODEL DRUG TIMOLOL...............25 
Chapter 5 EXPERIMENTAL......................................................................................28 
5.1. Preparation of Silk Fibroin Solution by Ajisawa’s Solution ..........................28 
5.2. Preparation of Drug Loading Reservoirs ........................................................30 
5.2.1. Preparation of Different Forms of SF .........................................................32 
5.2.2. Preparation of SF/HA Films .......................................................................33 
5.2.3. SF Film Crosslinked with Glutaraldehyde..................................................33 
 vi
5.2.4. Freeze-Dried SF..........................................................................................34 
5.3. Characterization of the Membranes ................................................................34 
5.3.1. Solubility Tests ...........................................................................................35 
5.3.2. Analysis Methods .......................................................................................35 
5.4. Adsorption Experiments .................................................................................35 
5.5. Iontophoretic Experiments..............................................................................36 
Chapter 6 RESULTS ...................................................................................................39 
6.1. Characterization of the Membranes ................................................................39 
6.1.1. Effect of Post Treatment on the Structure of Silk Fibroin ..........................39 
6.2. Formation of SF Film .....................................................................................44 
6.2.1. SF/HA Films ...............................................................................................44 
6.3. Glutaraldehyde Cross-Linked SF Film ...........................................................47 
6.4. Adsorption Experiments .................................................................................47 
6.5. Diffusion Experiments....................................................................................49 
6.5.1. Passive Diffusion Experiments ...................................................................50 
6.5.2. Active Diffusion Experiments ....................................................................51 
CONCLUSIONS ............................................................................................................61 
REFERENCES ...............................................................................................................62 
APPENDIX A                                                                                                                A1
APPENDIX B                                                                                                                A2
APPENDIX C                                                                                                                A3
APPENDIX D                                                                                                                A4
 
 vii
 LIST OF FIGURES 
 
Figure 2.1 Drug level in blood for traditional (a) and controlled (b) drug delivery .........3 
Figure 2.2 1.  Iontophoretic delivery system 2.  Electrode system applied to the skin 
surface. .......................................................................................................................6 
Figure 3.1 a) Domestic silkworm building its cocoon b) Finished cocoon c) Reeled silk9
Figure 3.2 β pleated structure of silk fibroin a) Face view b) Side view........................11 
Figure 3.3 Scheme for the molecular shape of SF molecules in solution and solid state 
for aqueous system...................................................................................................13 
Figure 3.4 Conformation change of SF in solid state by immersion in methanol (Green 
boxes represent long-range ordered crystallite) .......................................................14 
Figure 3.5 The relation between conformation, quenching or casting temperature and 
(starting) concentration of silk fibroin, B.  mori [37] ..............................................15 
Figure 3.6 Chemical structure of hyaluronic acid [64] (arrow indicates carboxyl group)
..................................................................................................................................20
Figure 3.7 Structure of HA in its native form [70] .........................................................21 
Figure 3.8 Carboxyl-amino interaction in the chitosan-alginate polyelectrolyte complex
..................................................................................................................................24
Figure 4.1 Structure of timolol maleate salt. ..................................................................26 
Figure 5.1 Preparation of silk fibroin solution................................................................29 
Figure 5.2 Block diagram describing various forms of SF and SF/HA blends produced 
in this study. .............................................................................................................31 
Figure 5.3 Custom-made diffusion cell used for drug delivery experiments .................37 
Figure 5.4 Iontophoresis experiment set-up ...................................................................38 
Figure 6.1 SEM image of cross-section of a) Methanol treated SF (SFMT) membrane.  
Magnification: 12000x. b) Heat treated SF (SFHT) membrane.  Magnification: 
5000x........................................................................................................................40 
Figure 6.2 a) SEM image of freeze-dried SF sponge.  Magnification: 2000x. b) 
Magnification: 650x.  c) After methanol treatment.  Magnification: 2000x. d) First 
frozen then freeze-dried SF.  Magnification: 250x. .................................................41 
 viii
Figure 6.3 X-Ray diffractograms of SF films treated in methanol a) for 3 minutes (SF-
MT 3 min) b) for 6 minutes (SF-MT 6 min) c) for 10 minutes (SF-MT 10 min) d) 
Heat treated SF film dried at 45 oC. .........................................................................42 
Figure 6.4 Ft-Ir spectra of a) silk film and b) methanol treated silk film. ......................43 
Figure 6.5 SEM image of cross-section of soluble membranes.  Composition: 50% HA, 
50% SF.  Magnification: 10000x.  b) Composition: 70% HA, 30% SF.  
Magnification: 6500x. ..............................................................................................45 
Figure 6.6 SEM image of cross-section of insoluble membranes.  a) Composition: 15% 
HA, 85% SF.  Magnification: 6500x.  b) Composition: 10% HA, 90% SF.  
Magnification: 6500x. ..............................................................................................45 
Figure 6.7 X-Ray diffractograms of a) 10% HA insoluble film (smoothed). b) 15% HA 
insoluble film (smoothed). .......................................................................................46 
Figure 6.8 Ft-Ir spectra of a) HA film b) 10% HA, 90% SF soluble film c) 10% HA, 
90% SF insoluble film d) SF film ............................................................................48 
Figure 6.9 Results of adsorption experiment. Equilibrium concentrations. ...................49 
Figure 6.10 Passive drug delivery for SFGTA drug loaded film.  I=0. ..........................50 
Figure 6.11 a) Iontophoretic drug delivery for SFGTA drug loaded film.  b) Current 
application course with I=1 mA...............................................................................52 
Figure 6.12 a) Iontophoretic drug delivery for SFGTA drug loaded film.  b) Current 
application course of two current applications of I=2 and 4 mA.............................54 
Figure 6.13 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=4 mA a) Delivery of drug b) Current application course. .55 
Figure 6.14 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=2 mA a) Delivery of drug b) Current application course. .56 
Figure 6.15 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=1 mA a) Delivery of drug b) Current application course. .57 
Figure 6.16 Iontophoretic drug delivery for SFGTA membranes pulsed current 
application values of 1, 2, and 4 mA........................................................................58 
Figure 6.17 X-Ray diffractogram of methanol treated (10 min) SF film after 
iontophoretic experiment. ........................................................................................59 
Figure 6.18 X-ray diffractograms of SFGTA film a) Before iontophoresis b) After 
iontophoresis ............................................................................................................60 
 
 ix
LIST OF TABLES 
Table 3.1 Amino-acid content, g/ 100 g fibroin                                                              10 
Table 3.2 Some of the related companies with HA or HA-derived products on the 
market                                                                                                                              22 
Table 6.1 Insoluble Samples                                                                                           40 
Table 6.2 Weight ratios of the two components in the polymer matrices.                      44 
Table 6.3 Dose applications and corresponding drug release for iontophoretic 
experiments                                                                                                                    59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 x
CHAPTER 1                                                                      
INTRODUCTION 
 
Controlled delivery of drugs is a vast research topic studied by many scientists 
and researchers throughout the world.  In traditional drug delivery, concentration of the 
drug exhibit peaks, which may go beyond maximum desired level and waste the drug 
material or even, be toxic.  The desired level is between the minimum efficient and 
maximum desired level [1]. 
 
The recent researches in genetics study suggest that more drugs based on 
proteins and peptides will be in the market in the near future [2].   Though these drugs 
will be more efficient than those of today’s, and will be tailored to the specific needs of 
the patient, the only drug delivery route is the intravenous route for protein based drugs.   
This means the average patient will have to have several injections daily.   Injection is 
not convenient since it produces a sudden peak in blood drug concentration, is 
accompanied by pain, brings infection risk, and does not fit the pace of life of the 21st 
century individual. 
 
The aim of this study is to develop a drug loading reservoir from silk fibroin 
which could be used under passive and iontophoretic conditions.  Chapter 2 covers the 
subject of transdermal delivery.  In Chapter 3, preparation of soluble/ insoluble 
matrices, under different treatment conditions and blending agents as hyaluronic acid 
(HA), and glutaraldehyde (GTA) were explained.  Chapter 4 reviews previous studies in 
transdermal delivery, iontophoresis and studies on timolol maleate adsorption and 
delivery.  Procedures of SF matrix preparation, adsorption of TM and iontophoretic 
experiments are explained in Chapter 5. The results are given in Chapter 6.  
 
Transdermal route is one of the routes of drug delivery to the body.  
Transdermal drug delivery offers significant potential for the non-invasive delivery of 
drugs.  The skin provides a large, accessible surface area, in addition to avoiding the 
hepatic first-pass effect and chemical degradation in the hostile environment of the 
gastrointestinal tract [3].  Transdermal drug delivery systems employ a carrier that 
 supplies the therapeutic agent to the organism continuously at the desired level, while 
the human skin is practically built to protect the body from outer effects and foreign 
materials.  To overcome this barrier, various chemical, physical and electrical methods 
have been developed to help drug molecules penetrate the skin.  One of these methods 
is the iontophoretic method which incorporates a drug reservoir containing charged 
drug molecules, where the molecules are driven into the body by application of 
electrical current.  The transdermal iontophoretic delivery is gaining popularity as a 
new and convenient method.   
 
The positively charged silk fibroin, which has an isoelectric point around 4 is 
promising for controlled adsorption and desorption of positively charged drug 
molecules.  It is known that silk fibroin derived from Bombyx mori cocoon is being 
developed and utilized for purposes besides traditional textile material.  It is used as 
surgical sutures, food additives, and in cosmetics.  Its superior properties like 
biocompatibility, high thermal-stability, and microbial resistance had it proposed for 
purposes such as wound protection, substrate for cell culture, enzyme immobilization, 
soft contact lenses with high oxygen permeability, and drug release agents [4].  Fibroin 
can be easily made up to into various forms [5], like film, membrane, gel, powder, and 
fiber [6].  In this research potential of silk fibroin as a drug reservoir was investigated.  
Films and fibers were subject to drug uptake experiments and membranes were tested 
for drug transport through them.  Effect of current application on the diffusion rate and 
responsiveness of delivery to current is investigated.   
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CHAPTER 2                                                                       
TRANSDERMAL DRUG DELIVERY 
2.1. Controlled Drug Delivery 
 
Oral administration of drugs may deactivate the drug molecules or have toxic 
effects.  The concentration of the drug in the blood may exceed the maximum desired 
level, which results in side effects that can harm the metabolism and the drug material is 
wasted.  Oppositely, after a period of time, the concentration of the drug falls below the 
minimum effective level, which results in the wasting of the drug without making any 
effect as seen in Figure 2.1.a.  Also some of the drugs such as protein based drugs, and 
timolol, go under first-pass metabolism in the intestinal tract or liver [7].  An ideal drug 
delivery system possesses two elements: the ability to target and controlled release.  
Targeting will ensure a high efficiency of the drug and even more important it will 
reduce side effects.  Drugs that are supposed to kill cancer cells can also kill healthy 
cells when delivered to them1.  The reduction or even prevention of side effects can also 
be achieved by controlled release.  This case is shown in Figure 2.1.b where drug level 
in blood is kept at the right value. 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 Drug level in blood for traditional (a) and controlled (b) drug delivery 
                                                 
1As one example where targeting can be important, in the UK alone there are 44,000 skin carcinoma 
cases per year, of which 2000 are fatal [3]. 
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2.2. Methods of Transdermal Delivery 
 
Human skin is virtually impermeable to molecules, exclusively to high molecular 
weight and non-lipophilic ones, since it basically evolved to protect the body from 
exterior effects.  The uppermost layer, which is the stratum corneum, poses the greatest 
resistance to penetration, with its distinctive architecture and its unique nature of 
interstitial lipoidal environment [8]. 
 
Transdermal therapeutic systems have found wide application and gained 
considerable commercial success in recent years, winning the competition with other 
controlled drug release systems such as peroral (osmotic minipumps), parenteral 
(nanoparticles and nanocapsules), subcutaneous (implants), intracavitary (inrauterine 
inserts and various suppositoria), buccal, etc [1].  Transdermal drug delivery is a viable 
administration route for potent therapeutic agents which cannot withstand the hostile 
environment of the gastrointestinal tract and/or are subject to considerable first-pass 
metabolism by the liver [9].  The transdermal route can also permit the noninvasive 
delivery of peptide-based pharmaceuticals, if the delivery can be improved by chemical 
enhancers, iontophoresis, or other means [10].  The methods of transdermal delivery 
fall into two main categories.  The first, which is the traditional delivery method, is the 
passive diffusion.  The other methods are active in that they employ some kind of 
physical or chemical phenomenon in order to enhance the permeation of the drug into 
the body. 
 
2.2.1. Passive Diffusion 
 
Also referred to as transdermal permeation or simple diffusion, passive diffusion is 
one of the established drug delivery routes such as topical applications, ointments, and 
patches applied without any enhancing mechanisms.  Passive diffusion offers limited 
possibilities, since human skin limits daily dosage delivered at around 10 mg from an 
acceptable sized patch [11].  Concentration gradient is the driving force for delivery in 
passive diffusion.  Nicotine patches as an aid for smoking cessation is the most widely 
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 known of “passive” patches.  Other transdermal delivery applications in use are small 
lipophilic drug molecules such as clonidine, estradiol, fentanyl, nitroglycerin, 
scopolamine and testosterone [12].   
 
2.2.2. 
2.2.3. 
2.2.4. 
Phonophoresis 
 
Phonophoresis uses an ultrasound wave to suddenly disrupt the molecular 
structure of the stratum corneum (horny layer) of the skin and drives the drug molecules 
through the skin.  Following disruption, stratum corneum restores its original 
configuration rapidly; however it was observed that some foreign molecules and 
bacteria may also penetrate along with the drug molecules.  This is unacceptable.  
Bruising is also another common after effect which is unpleasant for the patients.  
These drawbacks slashed the early hopes for phonophoresis [11].   
 
Electroporation 
 
Sometimes used simultaneously with iontophoresis, electroporation is the 
reversible permeabilization of the cell membrane.  In the case of dermal delivery, 
stratum corneum is electroporated.  Cells are exposed to a very brief and high voltage 
which opens the cell membrane pores temporarily.  Although the exact mechanism of 
access by electroporation remains unknown, it has been successfully applied for the 
transfection of DNA and macromolecules such as peptides, proteins, and other gene-
based compounds [11].  Use of electroporation has been suggested for cancer 
chemotherapy, delivery of peptides, polysaccharides, oligonucleotides, and genes [13]. 
 
Iontophoresis 
 
Iontophoresis is a noninvasive and painless means of delivering various drugs 
into the body [14].  Transdermal administration of drugs through the skin is assisted by 
electrical energy in the iontophoretic method.  Iontophoresis concerns small amounts of 
physiologically acceptable electric current to drive charged drug molecules into the 
body using an electrode with the same charge of the drug, producing electrostatic 
repulsion.  Skin is a permselective membrane with negative charge at physiological pH 
of 7.4 [15].  So the counterions are usually cations and electro-osmotic flow occurs 
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 (causing a net convective flow) from anode to cathode, thus enhancing the flux of 
positively charged drugs. Currently the US military is trying to develop a wristwatch 
sized iontophoresis device that will enable monitoring of the conditions of the soldiers 
in the battlefield from the satellite, and deliver the required drugs and vitamins etc by a 
signal sent to the device [11]. 
 
In Figure 2.2.1 iontophoretic delivery system as applied to a patient is seen.  In 
Figure 2.2.2: a) Negative electrode b) Positive electrode on top of the patch c) 
Positively charged drug molecules delivered to the blood circulation.  A bulk fluid flow 
accompanies this flow, which is called electro-osmosis.  In this thesis (and most of the 
literature), the term iontophoresis is employed so as to include the electro-osmosis 
phenomenon too [16].   
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 iontophoresis in our study were not high, as understood by slow depletion of the 
battery. 
 
It should be noted that patch is the membrane between the skin and the drug 
solution here; not the drug reservoir itself.  This is the same case with the SFGTA 
membranes of our study.  The mentioned desired properties like biocompatibility, 
ability to control release of the drug (i.e.  its permeability to the drug should be lower 
than that of the skin’s), and low electrical resistance apply to our membrane which is 
not drug loaded.  This is opposite of what is expected from a drug reservoir patch, 
which delivers the drug stored in itself.  When the drug is delivered through the patch, 
the drug reservoir matrix or liquid solution is placed on top of the patch.  In the case of 
delivery from the patch, the drug is loaded on the patch itself.  Both cases are 
investigated in our study. 
 
2.2.4.1 Previous Studies in Iontophoresis: Transdermal Patches, Ion 
Exchange Membranes 
 
Controlled transdermal iontophoresis by ion-exchange fiber have been studied 
[7, 18].  When the membrane acts as an ion-exchange fiber, there are mobile ions like 
Na+ or Cl- introduced into the system.  These mobile ions remove the charged drugs 
bound to the ion exchange groups of the fiber.  The advantage of the ion-exchange is 
that it enables greater control over the delivery than systems that deliver from a drug 
solution with the membrane placed in between.  In this study, several drugs, most of 
which are cations (TM is not included), have been loaded onto ion-exchange fibers and 
their delivery investigated.  Mathematical modeling of the delivery has been performed 
by classical transport equations after making some sound assumptions and 
simplifications.   Lipophilicity and hydrophilicity of the drug are other factors in drug 
delivery.  Among the drugs studied in this study [18] tacrine and propranolol are 
lipophilic while nadolol is relatively hydrophilic.  As a comparison, TM is a hydrophilic 
compound.  The equilibrium distribution of the drug between the fiber and the solution 
phases results from both electrostatic and hydrophobic interactions.  The chemical 
partition coefficient measures the tendency of the drug to pass to the hydrophobic fiber.  
As a result, it is proven that changing the (ion-exchange) fiber properties and the 
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 external solution can control delivery.  The external solution mentioned is the bathing 
solution for which the drug delivery is investigated.  This is not the same with our 
system but the rule of salt concentration effect applies to our receptor solution too since 
the mobile ions’ concentration is important there.  This phenomenon of ionic strength is 
a parameter in the delivery of TM. 
 
Influence of ionic strength in the adsorption and dissolution medium have also 
been investigated [19, 20, 21].  The membrane used was poly(acrylic acid) grafted 
poly(vinylidene fluoride) (PAA-PVDF).  The cation exchange process of the 
propranolol-HCl was found to be effected by ionic strength.  It was found that the low 
molecular weight drugs’ delivery performance diminishes by increase in ionic strength; 
on the contrary, high MW drugs’ deliveries were enhanced.  Spectroscopic analysis of 
timolol concentration was carried out.  Timolol was also investigated for comparison 
with propanolol-HCl. 
 
Transdermal iontophoresis of tacrine loaded onto a commercially available ion-
exchange fiber which was tested in vivo on human volunteers using silver/silverchloride 
(Ag/AgCl) electrodes [22] and the reliability of in vitro studies have been questioned 
using excised skin membranes by observing the release of levodopa and metaraminol 
using ion-exchange fibers [23].  Effect of pH and ion-exchange groups was found to 
have a great effect on the deliveries of these drugs.  It was stated that studies performed 
using excised calf skin may not properly simulate the real in vivo delivery results since 
the epidermis layer of the excised skin is usually absent or damaged.  This leaves back 
only the stratum corneum, which is stated not to govern delivery for most of the time 
and consequently the patch itself is controlling delivery.  This can be misleading and 
even dangerous.   
 
2.2.5. Selection of Electrodes 
 
The reason for choosing Ag/AgCl electrodes is that these electrodes do not 
cause pH shifts as the Platinum (Pt) electrodes do [22, 7].  On the other hand, Pt 
electrodes can be used for changing pH when desired.  Commercially available 
electrodes were used in our study. The phosphate buffered saline containing 6.22 g/l 
NaCl favours the electrode reactions in addition to making the solution isosmotic [24].  
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CHAPTER 3                                                              
DRUG RESERVOIR MATRIX: PREPARATION OF INSOLUBLE 
SILK MATRIX 
3.1. Silk Fibroin 
 
Silk is produced by arachnids (spiders) and insects as a building material for 
cocoons, webs etc.  [25].  In Figure 3.1.a the cultivated larvae of the moth Bombyx mori 
(domestic silkworm) is in the process of producing the type of silk that is of interest to 
us in our research.  After the cocoon is finished (Figure 3.1.b), a handful of cocoons are 
reeled to make the well-known silk thread as seen in Figure 3.1.c.
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 [29, 30, 31], except proline [32].  The highly repetitive sections are composed of 
glycine, alanine and serine (approx.  85% in total) in a rough 3:2:1 ratio and the amino 
acid sequence is expressed roughly as Gly-Ala-Gly-Ala-Gly-Ser [33].  Freddi et al. has 
studied the dissolution of silk fibroin in a solvent [31].  For time zero in the dissolution, 
amino acid percentage given is that of native silk fibroin.  A portion of the amino acid 
sequence of silk fibroin produced by Bombyx mori has been identified [30].  The 
crystalline region of silk fibroin is reported to compose mainly of the repetitive element 
Gly-Ala-Gly-Ala-Gly-Ser, and in the amorphous domain of silk fibroin is found the 
amino-acid sequence Thr-Gly-Ser-Ser-Gly-Phe-Gly-Pro-Tyr-Val-Ala-Asp-Gly-Gly-
Tyr-Ser-Arg-Arg-Glu-Gly-Tyr-Glu-Tyr-Ala-Trp-Ser-Ser-Lys-Ser-Asp-Phe-Glu-Thr. 
 
Table 3.1 Amino-acid content, g/ 100 g fibroin  
Amino acid Mukhamedzhanova et al.[29] Li et al.[30] Freddi et al.[31] 
Lys 0.51 0.63 0.33 
His 0.30 ND 0.20 
Arg 1.00 0.95 0.62 
Asp 2.43 2.75 1.65 
Thr 1.25 1.09 0.96 
Ser 13.18 9.91 11.48 
Glu 2.09 1.30 1.37 
Pro 0.53 ND 0.67 
Gly 33.34 35.08 43.68 
Ala 26.61 30.75 29.34 
Val 2.62 4.26 2.23 
Ile 0.87 1.59 0.66 
Leu 0.67 1.05 0.58 
Tyr 11.42 8.03 5.30 
Phe 1.2 1.24 0.73 
Met NR 1.37 0.10 
Cys NR ND 0.10 
ND: Not detected NR: Not reported 
 
 
Figure 3.2.a shows the polypeptide chains forming antiparallel β pleated sheets 
in which the chains extend parallel to the fiber axis.  Bombyx mori silk contains at least 
two major fibroin proteins, light (25 kDa) and heavy (325 kDa) chains [34]; while 
various figures are reported for the average molecular weight like 350 kDa [5].  
Actually, it was reported that upon dissolution, native fibroin which possesses light (25 
kDa) and heavy (350 kDa) chains, decomposes to a mixture of polypeptides of various 
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 sizes [28].  This is significant information considering the N termini of the chains play 
important role in intermolecular interactions.  The variety of the amino acids supplies 
many reaction sites such as amino, carboxyl, phenol, and imidazole groups [5].  Lysine 
residues and N-terminal of chains are the primary source of amino groups.  Free amino 
groups are also found on the histidine, arginine, and tryptophan amino acids [35].  
These groups have significant potential for any probable interactions such as crosslinks 
or electrostatic interactions. It is reported that silk fibroin has many hydroxyl residues 
e.g., Ser 10.6 mol%, Tyr 5.0 mol%, and Thr 0.9 mol% although carboxyl and amino 
group content was actually low (3.9 mol%) based on the amino acid composition of silk 
fibroin [36]. 
 
 
 
 
 
 
 
 
Figure 3.2 β pleated structure of silk fibroin a) Face view b) Side view 
 
The Gly side chains extend perpendicular from one surface while its Ala or Ser side 
chains extend from the other surface (Figure 3.2.b).  Hydrogen bonds lie within the 
plane of the sheet.  These polypeptide chains are almost fully extended, so silk fibers 
are only slightly extensible, though strong.  However the β sheets interact with each 
other only through weak Van der Walls forces [29], rendering the fibroin flexible.  
Along with the pleated β sheet structure, there are also amorphous regions in the fibroin 
in which bulky residues of Tyr, Val, Arg and Asp occur.  The amorphous region 
enhances extensibility while diminishing elasticity [25].   The silk film cast from 
aqueous solution consists of two structures: the α-form (or silk fibroin I) and the β-form 
(or silk fibroin II) [37]. 
 
Recently, several researchers have investigated the silk fibroin (SF) as one of 
promising resources of biotechnology and biomedical materials due to its unique 
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 properties including good biocompatibility, good oxygen and water vapor permeability, 
biodegradability, and minimal inflammatory reaction [6], microbial resistance [4], 
blood compatibility [26].  Some of these functionalities of fibroin were attributed to the 
amorphous and not the crystal region of fibroin and a fractal approach was developed to 
explain penetration of water vapor into regenerated silk fibroin [26].  This region is 
responsible for the elasticity of silk compared to fibers of similar tensile integrity, and 
although US Pharmacopeia lists silk as non-biodegradable since it does not “lose most 
of its tensile strength within 60 days”, it is actually degradable over longer periods by 
the proteolytic degradation mechanism [34].  SF in regenerated forms has been used as 
surgical sutures, food additives, and cosmetics, and using of SF has been proposed for 
many purposes such as drug delivery (controlled release [34], a carrier of controlled 
release medicine [30]), soft contact lenses with high oxygen permeability, wound 
protection, substrate for cell culture, and enzyme immobilization [4].  Silk fibroin-based 
wound dressing was developed that could accelerate healing and could be peeled of 
without damaging newly formed skin; and it was also reported that silk fibroin 
membrane can be used to preferentially remove water from a mixture of water and 
alcohol [27].  Fibroin has also certain nutrient value to humans [5].  Uses of silk as burn 
wound dressings, templates for osteogenic tissue formation were listed in a study that 
investigated a silk-fiber matrix as a suitable material for tissue engineering anterior 
cruciate ligaments (for knee joints) [38].  It is an interesting point that hyaluronic acid is 
a major component of the synovial fluid which lubricates the knee joints.  The 
interactions of SF and HA can draw interest from this aspect too.  Silk fibroin is 
reported to have been blended with cellulose, PVA, polyurethane, cellulose acetate, 
chitosan, sodium polyglutamate, polyethyleneglycol (PEG) [39], sodium alginate, and 
S-carboxymethyl keratin [40]. 
 
Silk fibroin contains disulfide crosslinks among its heavy and light chains; 
however these do not normally participate in intramolecular reactions [41].  Cysteine 
residues of the silk fibroin may be attempted for such a modification, though there are 
few studies about this in literature [42]. 
 
Silk fibroin has high versatility that it can be processed into foams, films, gel, 
powder, fibers and meshes with good strength [5, 34].  Pulverized fibroin has also been 
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 commercialized [43].  SF powder has been used in the production of hydroxyapatite-SF 
nano-composite sol for the purpose of producing artificial bone or dental roots [44]. 
3.2. Methods of Silk Fibroin Matrix Preparation 
 
Silk fibroin films prepared by casting the aqueous protein solution and drying at 
25 oC as seen in Figure 3.3 are soluble in water.  Such films have a micro phase-
separated structure consisting of crystal and amorphous regions [45].  These films 
should be fixed with physical or chemical crosslinking.  Bifunctional agents such as 
glutalaldehyde are usually used for crosslinking.  However, unreacted glutalaldehyde 
remaining in the structure is cytotoxic.   
 
Figure 3.3 Scheme for the molecular shape of SF molecules in solution and solid state 
for aqueous system 
 
Crystallization by immersing in aqueous ethanol or methanol (Figure 3.4) is another 
widely used method to induce structural change from random coil to β-sheet structure 
[46].  Degree of crystallinity increases up to 11%2.  Methanol treatment was applied to 
fibroin membranes for varying intervals of 3 to 60 minutes and their oxygen 
permeabilities were investigated.  Films were cast from 1% silk solution, dried at 25 oC 
and 65% relative humidity (RH), immersed in 1:1 methanol-water solution, and again 
                                                 
2 It should be noted that, in literature it is also reported that β sheets are not necessarily in crystalline form 
[35].  That is to say, there might not be a linear quantitative relation between the crystallinity of the 
samples and their β sheet percentage. 
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 conditioned at 7 days at 25 oC and 65% RH [45].  It is stated that the amorphous region 
of silk is responsible for oxygen permeation and duration of methanol treatment can 
affect this permeation behavior [47].  Zhang has used a unique and peculiar physical 
treatment technique to achieve anti-parallel β-sheet structure, which involves stretching, 
compressing and standing under high humidity [5].  The starting solution concentration 
is also of critical importance for the structure of the fabricated films (see Figure 3.5). 
 
 
 
 
 
 
 
Figure 3.4 Conformation change of SF in solid state by immersion in methanol (Green 
boxes represent long-range ordered crystallite) 
 
Undegraded native fibroin solution from cocoons was prepared in literature by 
this method: after reeling by standard methods by machine, degumming was performed 
in 50 times (v/w) boiling aqueous 0.05% Na2CO3 solution.  Then the purified fibroin 
was dissolved in 15 times standard Ajisawa’s reagent (CaCl2, EtOH, water, 1:2:8 mole 
ratio) [28].  This is the universally accepted dissolution method which is also used in 
our study and elsewhere [49].  Ajisawa’s and other salt solutions used to dissolve silk 
are referred to as chaotropic solutions (LiSCN, LiBr, NaSCN, and CaCl2).  The 
degradation of fibroin and resulting molecular weights of the protein by various 
treatments have been investigated, and it was found that the CaCl2 treatment does not 
cause appreciable degradation, so it is used in this study.  Removal of sericin in hot 
alkaline solution causes some degradation of the heavy chain of silk, so it should be 
performed at same time and temperature every time.  This could be checked by SDS-
PAGE (polyacrylamide gel electrophoresis method employing polyacrylamide gel with 
sodium dodecyl sulfate buffer) analysis or alternatively rheologic methods.  It is also 
noted that the solution of intact (undegraded) fibroin has a strong tendency to gel and so 
it is advised that it is dialyzed just prior to use, which was experienced and practiced in 
our study.   
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Figure 3.5 The relation between conformation, quenching or casting temperature and 
(starting) concentration of silk fibroin, B.  mori [37] 
 
Formic acid has also been employed as a solvent for the dissolution of silk 
fibroin instead of the ternary solvent of CaCl2/EtOH/water [6, 35].  It has been stated in 
literature that dissolution of SF is desired when is used for purposes other than textile, 
like film, porous membrane, gel, and powder.  Aqueous solution of concentrated neutral 
salts like calcium chloride have a tendency to become unstable and precipitation of SF 
is possible due to low solubility (such a phenomenon has been observed in our 
experiments as a small precipitate during dialysis stage).  Another advantage of 
dissolution in formic acid is that when SF is going to be blended with other polymers, 
solubility of the blending agent in the concentrated salt solution is usually problematic.  
This is not the case with formic acid, which has been reported to be a good co-solvent 
for blending applications.  In our case, blending of the two components SF and HA will 
be performed in aqueous medium employing their solutions in water.  In the mentioned 
study, solutions of SF in formic acid and water have been studied, and also a film was 
also cast from the formic acid solution of SF.  Although methanol treatment has been 
applied to the solution, it is understood that this was not applied to the cast film.  
Formic acid dissolution is found to create an effect similar to methanol treatment on the 
cast film.  This effect is the conversion of the amorphous structure to a β-pleated 
crystalline structure, bringing insolubility in water.  Structural characteristics and 
crystallinity have been investigated by XRD and Ft-Ir.  DTA and DSC have also been 
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 employed [6].  Solubility of the silk in water was not tested for the film, however it is 
discussed that in water fibroin molecules aggregate and entangle each other since SF is 
composed mostly of hydrophobic amino acids.  On the contrary, SF in formic acid is 
reported to be free of aggregates and entangled structures.  This is attributed to the 
charge repulsion effect between fibroin molecular chains since SF is positively charged 
in acid.  In this study it is suggested that aqueous SF solution is not transparent and 
unstable.  It is true that the solution is likely to become unstable when not handled with 
care; even so the aqueous SF solutions prepared by us were clear, transparent and stable 
at storage intervals shorter than one week. 
 
Effect of processing temperature on the morphology of silk membranes and also 
methanol treatment was investigated [40].  Various processing methods used are casting 
followed by air-drying or freeze-drying, mechanical shearing, compression, the 
Langmuir-Blodgett technique, and bubble blowing.  Molecular conformation of the 
resulting membrane can be controlled by the processing conditions such as solution 
concentration, solution temperature, quenching temperature, drying rate/ temperature/ 
and time, the presence of an electric field, pH, the presence of certain enzymes and the 
type of solvent.  Increased drying temperature effect was discussed above.  Effect of 
decreasing pH is the precipitation of the protein as β pleats.  The random coils and α 
forms open (unfold), enabling the rebuilding of the hydrogen bonds between amino acid 
chains.   Among these parameters, we manipulated composition and drying conditions 
in this study.  Effect of electric field was examined by XRD at desorption (delivery) 
stage of the research, which caused crystallization of the membranes.  Silk was taken 
from the gland of the silkworm in this study and also regenerated silk was used.  After 
degumming, dissolution, and dialysis by standard methods, the membranes were cast 
onto Petri dishes and dried at 30 oC in air for 48 h.  Subsequently, the membranes were 
treated with a 75 vol% aqueous methanol solution for 15 minute and dried.  The 
resulting membranes were 15 µm thick.  Films made of regenerated fibroin did not 
exhibit the small particles or the irregular morphology; however they exhibited grains 
and nanofibrils in their morphology.  It is found that higher processing temperature 
leads the amorphous structure in the membranes to convert to β-pleated structure.  This 
structure produces morphology with aggregated fibrils. 
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 3.3. Previous Studies with Silk Fibroin 
 
3.3.1. SFGTA Blends 
 
Sufficient mechanical strength is required for most of the applications 
mentioned at the previous section.  Nevertheless the silk fibroin is prone to get brittle in 
its dry state.  The brittleness can be a drawback for the use of fibroin membrane as a 
patch in transdermal drug delivery [50].  SF was blended with other polymers in order 
to overcome the drawback of SF itself by improving mechanical properties [6].  For this 
purpose, improvements in physical properties of fibroin-based biomaterials have been 
sought by blending with other agents, including chitosan, sodium alginate, poly(vinyl 
alcohol) (PVA), and cellulose, of which PVA was found to be effective [50,4].  When 
blended with PVA, fibroin is said to make up a hydrogel with excellent moisture 
adsorbing and desorbing properties and elasticity [27].  SF/PVA blends were also used 
for enzyme immobilization [48].  In our study, blending the fibroin with hyaluronic acid 
(HA) can eliminate this disadvantage.  If a cross-linking agent is used, it is in interest 
that this agent does not ruin the biocompatibility of the membrane.  HA is similar to 
PVA in that both are well-known biocompatible materials which are soluble in water 
and have a high water retention capacity.   
 
Porous composite membranes of regenerated silk fibroin and PVA were 
prepared for use as an immobilization matrix for glucose oxidase, as a glucose 
biosensor.  Polyetyleneglycol (PEG) has been added to the casting solution to decrease 
mass-transfer resistance and obtain a porous structure [50].  Porous blend gels of silk 
fibroin-poly(vinyl alcohol) were prepared by freeze drying technique [4].  Same authors 
have also applied freeze drying and freeze-thaw techniques to aqueous solutions of SF 
to prepare porous films in a previous study.  Parameters that affect the properties and 
structure of the film are concentration, freezing temperature, and the number of freeze-
thaw cycles.  The air dried gels were found to have an higher crystallinity and 
mechanical strength, while the freeze-dried gels have a more porous structure.  As the 
freezing temperature was lower, the crystallinity increased.  This may contribute to 
insolubility in water, though no mention of the solubility phenomenon is made in the 
study.  More than 50 % PVA addition was required to improve strength.  The gels are 
composed of wall-like material defining separated compartments. 
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 Silk fibroin-poly(ethylene glycol) conjugate films were developed and their 
structure and mechanical properties were examined [51].  In order to dissolve 
degummed SF, a concentrated aqueous solution of LiBr (9 M) was employed in the 
mentioned study and then the solution was dialysed against water.  PEG and SF were 
reacted in the aqueous solution containing 0.1 M sodium borate as modifier.  After the 
reaction took place, the eluate of SF-PEG was collected, unreacted materials and 
modifier removed accordingly, and solution was brought to 1% (w/v).  The membranes 
were cast on polyethylene films.  An SF film having a β-sheet structure was prepared 
by immersing the film in a 50% (v/v) methanol-water mixture for 4 h at room 
temperature and drying the immersed SF film at ambient relative humidity at room 
temperature (methanol treatment).  DSC tests were performed.  Circular dichromism 
(Cd) spectra results indicate a random coil conformation with small amounts of β-sheet 
and helix structures for the SF film.  The methanol treated SF film exhibits only an 
endothermic peak at DSC, while the untreated film has an exothermic peak at 228 oC 
attributed to the transition from random coil to β-sheet. 
 
3.3.2. 
3.3.3. 
Freeze-Dried SF 
 
In literature porous silk fibroin material has been prepared by a freeze-drying 
method [52], and its enzymatic degradation was investigated [30].  This method 
produces porous, spongy structures with a high surface area.  SF was also blended with 
PVA and freeze-dried as mentioned above.  
 
SF Film with Glutaraldehyde 
 
SF membranes are usually fixed by crosslinking with glutaraldehyde (GTA).  
Although the exact mechanism of protein cross-linking with glutaraldehyde is not yet 
clearly defined, certainly the ε-amino groups of the lysine residues and the N-terminal 
amino groups of the proteins are involved and there is not an absolute method to 
determine the degree of crosslinking for GTA [53].  Lysine residues make up of 0.5-0.6% 
of the amino group composition of SF (Table 3.1).  Seves et al. fixed silk fabric samples 
with a 2.5% GTA solution [43].  GTA crosslinking of dermal sheep collagen was 
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 performed and compared with the new method of successive epoxy and carbodiimide 
cross-linking [54].  Enzymes are usually immobilized in protein materials such as the silk 
fibroin using GTA, however methanol treatment was reported to yield better results in 
terms of the immobilized enzyme sensitivity [48].  The reason for using GTA films for 
drug loaded films and membranes without drug in this study was that TM dissolves in 
polar solvents such as ethanol or methanol.  GTA crosslinking provide our membranes 
sufficient mechanical strength for iontophoretic experiments.  Another alternative could 
be using heat treatment method.  This could be applied to incorporate drugs into an 
insoluble film structure.  Heat treatment has some disadvantages.  The films acquire 
wrinkles and even small cracks due to very rapid drying.  Fabricated structure is not 
perfectly standardized. Same standardization problem can be observed for methanol 
treatment. 
 
 
3.3.4. Other Studies with Silk Fibroin 
  
Permeabilities of ions such as KCl, K2SO4, K2HPO4, MgCl2, CaCl2, and 
MgSO4, across silk fibroin membrane were measured as a function of concentration of 
external solution in the system of silk fibroin membrane-electrolyte solution.  The SF 
films are known to have amphoteric properties with the positive and negative charged 
groups they bear [55, 56].  Silk fibroin membrane was also investigated for fluoracil 
drug [57].  The weak acid and base groups are amino and carboxyl groups respectively.  
The silk fibroin membrane is reported to have an isoelectric point about pH 4.5.  This 
dictates that our fabricated SFGTA membranes act as cation exchanger at the subject 
pH of 7.4.  Silk fibroin has a positive charge at this pH.  Transport of pharmaceuticals 
through the membrane was investigated in the pH range from 3.0 to 9.0.  The positively 
charged pharmaceutical was excluded from the membrane below the isoelectric point 
[58]. 
 
3.4. Hyaluronic Acid 
 
Natural polysaccharides, such as chitin, chitosan, cellulose, hyaluronic acid, 
have recently been re-evauluated and found to be useful resources and functional 
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 materials.  The homopolymers of were polysaccharides inadequate to meet the diverse 
demands for materials, so they are blended with other polymers [59].  Hyaluronic acid 
(HA) is a linear acidic polysaccharide consisting of alternating units of D-GlcA and D-
GlcNAc: [?4)-β-D-GlcpA-1?3)-β-D-GlcpNAc-(1?]n, (Figure 3.6).  Alternating 
disaccharide units of N-acetyl-d-glucosamine and d-glucuronic acid are joined by 
alternating β-(1–3) glucuronidic and β-(1–4) glucosaminidic bond [60].  It is a major 
component of the extracellular matrix of connective tissue and is found in high 
concentrations in umbilical cord, vitreous body of the eye, and in synovial fluid.  HA is 
quite distinct from other glycosaminoglycans.  All carry sulphate groups and their 
polysaccharide chains are relatively short (<100 kDa).  To the contrary, it is the only 
non-sulfated glycosaminoglycan (GAG) in the extracellular matrix [61].  This means 
the primary structure of HA contains neither sulphate groups nor peptide as it is not 
covalently bound to proteins [62].  Although it consists of a single polysaccharide chain 
like other glycosaminoglycans, HA usually has a high molecular weight (105–107 
g/mol) depending on the length of the chains [63].   
 
Figure 3.6 Chemical structure of hyaluronic acid [64] (arrow indicates carboxyl group) 
 
HA possesses a high density of potential hydrogen-bonding sites, but in addition, it 
is a strongly polyanionic molecule due to Na+ or K+ ions complexed between 
polysaccharide strands.  It is a weak polyacid, as only one charge can be present for 
each density for two residues in its repeating unit [65].  HA can adopt a number of 
distinct double helical conformations in a variety of packing arrangements as a function 
of its hydration, ionic environment and temperature [66].  A typical HA strand is shown 
in Figure 3.7.  This strand adopts secondary structure in aqueous solution, and because 
of the hydrogen bonding which gives stiffness to its chain, it behaves as expanded 
random coil with a diameter of 500 nm.  The chain becomes entangled already at low 
concentrations in the order of 1 g/l [67].  
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Figure 3.7 Structure of HA in its native form [70] 
 
The attention devoted to HA in the biomaterials field has been motivated based 
upon its specific chemical properties.  It can be functionalized with reactive groups, 
undergo cross-linking reactions and produce materials in the form of hydrogels [68].   
 
Its immunoneutrality makes HA an excellent building block for biomaterials to be 
employed for drug delivery systems [69].  Since HA is biocompatible and 
biodegradable, it has been popularly used as temporal scaffolds for tissue engineering 
or drug delivery devices for therapeutic agents.  HA was cross-linked to form a three-
dimensional chain network (hydrogel) after chemically modifying HA with cross-
linkable functional groups.  A wide variety of polyfunctional cross-linking agents were 
used to form the hydrogel structure [71].  HA has been used as, a viscoelactic 
biomaterial for medical purposes, in cosmetics thanks to its high water retention 
capacity, and in drug delivery systems thanks to its biodegradability [72].  Polymer-
drug conjugates for controlled release, crosslinking into hydrogels, and surface coating 
uses of HA was also summarized [61]. 
 
3.5. Previous Studies with Hyaluronic Acid 
 
Prestwich et al (1998) [73] gives short but valuable insight about the drug delivery 
uses of HA after providing some general information about HA.  The uses of HA in 
drug delivery started as and adjuvant for ophthalmic drug delivery and etc.   
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 Table 3.2 Some of the related companies with HA or HA-derived products on the 
market [73] 
Company Product 
Anika HA-N-acylurea derivatives for surgical 
applications, treatment of osteoarthritis, 
bone fracture healing 
Hyal Pharmaceuticals Corp. Combining HA with existing drugs: such 
as diclofenac 
Seikagaku Corp. HA-enzyme conjugates 
Telios Pharmaceuticals, Inc. HA hydrogels for tissue engineering 
 
HA is reported to have been blended with PVA for ophthalmic use, and with 
carboxymethylcellulose (carbodiimide crosslinked) for a bioabsorbable film for 
prevention of postsurgical adhesions, for wound-healing applications with collagen.  It 
is understood that HA blends are proposed to be used for coatings in microspheres, 
which can be used for transcmucosal drug delivery (such as in nasal sprays).  Several 
drug delivery uses of HA are listed in Table 3.2.  HA was used as a drug reservoir as 
well.  Lim et al [74] have prepared microspheres of HA and chitosan and evaluated the 
in vitro drug release properties and mucoadhesion of them.  Bioadhesion is desired in 
drug administration through mucosal routes but not necessarily for dermal delivery. 
 
HA has been also used as an attractive building block for new biocompatible 
and biodegradable polymers with applications in drug delivery.  One study concerns the 
production of a crosslinked hydrogel [61].  Poly(ethylene glycol)-proiondialdehyde 
homobifunctional reagent is blended with HA (which is converted to its adipic 
dihydrazide (ADH) form).  Drug loading onto this hydrogel was performed by in-situ 
polymerisation.  This is achieved by dissolving the drug molecules in water or ethanol 
and then simply adding the casting solutions.  (This method is same with the drug 
loading method used for the SF-GTA films in the current study.) The drug release was 
studied by cutting the drug-loaded hydrogel into small pieces to fit in the cuvette of the 
UV spectrophotometer.  It was observed that the drugs were released to the PBS 
solution in the first ten minutes, following a first order kinetics. 
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 The release of peptides and proteins from hydrated hyaluronic acid ester and 
partially esterified hyaluronic acid membranes have been investigated [75,76].  
Although our research does not concern protein delivery, it is worth noting what affects 
the release of proteins to make comparisons.  The fundamental motivation of choosing a 
model drug having similar properties with proteins was explained above.  Since these 
molecules are inherently larger, they are highly dependent on porosity, cross-linking, 
pore size etc.  This is evident by the abrupt change in release behaviour over narrow 
ranges of esterification.  It is noted that constant or zero-order release of therapeutic 
agents is desirable, while for some drugs pulsatile release is desired.  These studies 
concern the development of implantable controlled release matrices.  One important 
criterion for these matrices is biodegradability in order to rule out the need for surgical 
removal. 
 
A scaffolding material for tissue regeneration has been investigated [69].  This 
is a porous matrix of hyaluronic acid (HA) and collagen prepared by a freeze-drying 
technique.  Collagen to HA ration is 8:2.  HA used has molecular weight of 120-150 
kDa.  Experimental section of this study gives information about the preparation and 
characterization of an HA blend matrix.   
 
Negatively charged HA has also been used for the coating of nanospheres for 
ocular drug delivery [77].  Sodium hyaluronate used had a molecular weight higher than 
106 g/mol similar to the figure of our study.  There is no cross-linking associated with 
coating, instead the nanospheres are coated by (1) chain entanglement of HA, (2) 
adsorption of HA, and (3) electrostatic interactions of HA and a cationic surfactant.  
Similar electrostatic interactions of the cationic and anionic substance are established in 
our study. 
 
3.6. Insoluble Matrix Preparation 
 
A probable route of interaction between HA and SF can be among the carboxyl 
group of the HA with the amino group of SF.  This reaction can result in the formation 
of amide bonds.  The carboxyl group can react with the amino group especially at low 
pH medium, where the carboxyl group is at its anion state (COO-).  The stoichiometric 
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 ratio of the amino groups and carboxyl groups were calculated.  The optimum ratio of 
HA to SF is around 5 to 10 %.  This is explained in detail in section 3.7. 
 
3.7. Preparation of Silk Fibroin/Hyaluronic Acid Solution 
 
 In order to have an insoluble SF/HA film, it must be assured that the two 
molecules are incorporated effectively.  The sites of modification on hyaluronic acid are 
the carboxyl and alcohol groups.  Carboxyl groups of HA can be reduced (anions of 
carboxyl groups) and the amino groups of the silk fibroin can be oxidized (for example 
by reacting with an organic acid) (cations of amino or imino groups).  This reaction 
scheme eliminates the need for a cross-linking agent such as glutaraldehyde. 
 
 
 
 
 
 
 
 
Figure 3.8 Carboxyl-amino interaction in the chitosan-alginate polyelectrolyte complex 
 
Such an interaction is observed when amine groups of chitosan interact strongly 
with carboxyl groups of alginate, forming a complex (Figure 3.8).  Due to the 
protonation amino group on chitosan and ionization of carboxylic acid group on 
alginate, the stability of the formed complex is influenced by environmental parameters, 
such as pH and ionic strength [78].  When no cross-linking agent is employed for the 
production of the polyion complex, this is an advantage over the blends that have been 
produced by making use of cross-linking agents such as formaldehyde, dimethylolurea, 
dimethylolethylene urea that are not biocompatible. 
 24
  
CHAPTER 4                                                                       
LOADING AND DELIVERY OF MODEL DRUG TIMOLOL 
 
Timolol maleate (TM) is a β-adrenergic blocking agent used in the management 
of hypertension and etc.  It is known to undergo extensive first-pass hepatic 
metabolism, which makes it a potential candidate for transdermal drug delivery.  The 
maleate salt of timolol has a formula weight of 432.5 g.  The TM used in this study is in 
two forms:  first is timolol maleate purchased from Sigma, and a 0.5% eyedrop solution 
of timolol.  TM has an empirical formula C13H24O4N4O3S.  C4H4O4. TM is widely used 
in iontophoretic studies [79], and it was also loaded on patches [80]. 
 
Stamatialis et al. (2002) have studied controlled transport of timolol maleate 
through artificial membranes under passive and iontophoretic conditions [16].  The 
membranes that have been investigated are commercially available membranes, which 
range from microporous to mesoporous.  The mesoporous membranes showed no 
difference of transport rate with current rates.  So, they are not suitable.  It was 
understood that the molecular weight cut-off values are not a reliable way of evaluating 
membranes’ transdermal delivery performance.  The dense membranes are supposed to 
have a poor transport performance.  However, it is of concern to investigate whether 
there will be any changes in structure when current is applied, or the drug molecules 
stuck in the film will be mobilized by swelling and the current application.  The most 
suitable type was the microporous membrane that enabled control of TM transport by 
current application.  This membrane has a resistance lower than skin.  The type of the 
transport cell is not same with the diffusion cell, which was employed in our research.  
Adsorption to the membranes has also been investigated by dipping the membranes in a 
solution of TM, since adsorption can be undesirable for the purpose of use as a 
membrane in between.  This subject was discussed in Chapter 5. 
 
Timolol uptake and release by imprinted soft contact lenses made of N,N-
diethylacrylamide and methacrylic acid (MAA) has been studied [79].  This is 
interesting since SF is reported to be suitable for use in soft contact lenses with high 
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 oxygen permeability.  Molecular imprinting method was employed for the production 
of the weakly cross-linked membrane.  That is, TM was introduced into the medium 
while creating the membrane, in order to leave behind pores perfectly tailored for 
timolol.  The adsorption of TM in this study gives valuable insight about the 
mechanism of adsorption of TM.  Adsorption of TM has been fit to Langmuir isotherm.  
The factors affecting adsorption was investigated.  These are pH, and interaction of 
timolol by carboxylic groups of the polymer MAA (which can be manipulated by 
changing composition).  Timolol interaction with carboxylic groups of MAA is 
expected to be ionic since timolol was positively charged in the loading experiments 
(pKa of protonated timolol is 9.2), and/or through hydrogen bonding with the amino, 
ether and hydroxyl groups of timolol structure (Figure 4.1).  This information suggests 
that the TM may interact with carboxylic groups of the hyaluronic acid. 
 
 
Figure 4.1 Structure of timolol maleate salt. 
 
The imprinted gels exhibited a better performance in adsorption tests.  This is 
related to the fact that they are weakly cross-linked compared to the unimprinted gel.  It 
could be stated that cross-linking reduces adsorption capacity, especially when there is 
too much of it.   
 
The isoelectric point of the membrane is of critical importance in the delivery of 
a cationic drug like TM.  The isoelectric point of the SF membrane is around pH 4.0 
[57].  The isoelectric point dictates that above pH 4.0, the membrane will act as a 
cation-exchanger and below pH 4.0 it will act as an anion-exchanger.   Below the 
isoelectric point, cations tend to be excluded from the membrane.  So, in order to 
control the rate of drug delivery pH can be manipulated as well as the current density.  
Changing the composition of the polyion complex could control the delivery behavior.  
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 As the composition is changed, the responses of the patch to pH and current density 
changes could be altered. 
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 CHAPTER 5                                                                  
EXPERIMENTAL 
5.1. Preparation of Silk Fibroin Solution by Ajisawa’s Solution 
 
In order to cast silk fibroin films from aqueous solutions, the preparation of the 
aqueous solution is handled first.  Silk fibroin aqueous solution is prepared by the 
universally applied Ajisawa’s method as mentioned in Chapter 3.  This method is 
reported not to cause considerable degradation of the silk structure and can be used 
safely [28].  The aqueous solution of the silk fibroin obtained by this method is prone to 
get unstable (gelling) and it is preferred that it is prepared just prior to use.  Preparation 
of silk fibroin is given in Figure 5.1. 
 
The cocoon silk of Bombyx mori was obtained in reeled form from Bursa 
Institute for Silkworm Research.  In order to assure complete removal of sericin; silk 
was processed three times in boiling 0.5 wt % Na2CO3 solution (98-100 oC) for 1 hour 
[6].  In order to avoid the water vapour bubbles to be confined in the silk structure and 
then burst out, large beakers (2 L) were used.  The sample was rinsed with water at the 
end of each batch without squeezing, at the last run squeezed by hand, and dried at 
ventilated oven at 35 oC on a watch glass.  The silk was now degummed (free from any 
sericin) and consisted of only fibroin protein. 
 
1.5 g of the purified fibroin was dissolved in 20 times (weight/volume) ternary 
solvent CaCl2-ethanol-water (mole ratio=1:2:8) at 78 oC for 2 hours with shaking in 
water bath.  It was observed that less than 15 times solvent is insufficient to provide the 
physical mixing.  This solution was dialyzed for 3 days at 4 oC in cellulose tubing with 
a molecular weight cut-off value of 12000 against deionized water to remove CaCl2 and 
ions.  Dialysis water was changed frequently.  Fibroin molecules in aqueous solution 
aggregate and entangle each other by hydrophobic interactions because most of the 
amino acids in silk chain are hydrophobic [6], giving silk a random coil structure in 
water. 
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removed) 
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Aqueous fibroin 
solution ready 
(2.5% w/v) 
Figure 5.1 Preparation of silk fibroin solution 
  
 In order to check the removal of calcium, silver chloride precipitation test was 
applied to the dialysis water.  After the dialysis ended, dialysis bag was taken and 
precipitate of silk was filtered.  It was observed that the filtering of the precipitate is 
useful in preventing the agglomeration of fibroin molecules during the rotary 
evaporator step.  In the presence of the precipitate, it is possible that agglomeration is 
enhanced by the seeding effect of the precipitate for the crystallisation of the protein 
molecules.  The clear silk solution was concentrated to 10% (w/w) at the rotary 
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 evaporator at 43 oC (Buchi evaporator, set T to 47-48 oC), revolutions per minute to 60 
rpm.  The ideal method for concentrating is slow evaporation because elevating the 
temperature to accelerate evaporation causes the agglomerated particles to be formed in 
the solution.  Although it was reported that the solution can be concentrated by hanging 
the dialysis tube in air, in an air-ventilated room at room temperature [43], it was 
experienced by us that this would lead to gelling of the solution.  Extended periods 
cause the solution become unstable and cooling can not prevent this.  Actually, gelling 
of the solution was observed even at low temperatures like 4 oC after one month.  For 
this reason, slow evaporation was not employed.  Slow evaporation by hanging the 
dialysis bag at cool environment (like 10 oC) can prevent any occurrence of gelling.  An 
alternative to eliminate the evaporation step can be to avoid the dilution of the silk in 
Ajisawa’s solution and designing the final solution to have the desired concentration.  
All the same, this might cause an unstable solution. 
 
5.2. Preparation of Drug Loading Reservoirs 
 
The matrices to be used in delivery tests were prepared from different forms of 
silk fibroin and blends with hyaluronic acid and glutaraldehyde.  All of these fabricated 
matrices are shown in Figure 5.2.   
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Figure 5.2 Block diagram describing various forms of SF and SF/HA blends produced 
in this study. 
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5.2.1. Preparation of Different Forms of SF 
 
Silk fibroin films have been cast in different forms.  Pure silk fibroin (SF) films, 
SF/hyaluronic acid blend films, and SFGTA blend films were produced.  These films 
were dried at varying conditions.  In addition, some pure SF films were subjected to 
post treatment in 50 % aqueous methanol.  Different forms like freeze-dried fibroin 
have also been prepared.  For the first membrane composition, which is actually pure 
fibroin, the 10% SF solution was cast on a glass Petri dish and dried at 30 oC in air for 
48h.   
 
Some applications of hyaluronic acid were listed in section 3.5.  In order to 
produce a polymer matrix of silk fibroin and hyaluronic acid, the aqueous solutions of 
the both materials were mixed at varying proportions.  The aqueous solutions were 
dilute, the silk solution was 10 % (w/v) while the hyaluronic acid solution was 1 %.  
The resulting matrices were tested for solubility in water.   
 
5.2.1.1 Methanol Treated SF Films 
 
After the casting of the silk fibroin membrane, it can be treated with methanol, 
which is known to lead to crystallinity of the structure [6].  The silk fibroin is in random 
coil form in aqueous medium of neutral pH.  Placing the films in a 1:1 ratio aqueous 
methanol solution changes the conformation to an arranged state of the β sheets.  An 
immersion time longer than 3 minutes is sufficient for the film to become insoluble in 
water [45].  A change to β-pleated structure enables the formation of hydrogen bonds 
between the adjacent fibroin chains, thus making the film insoluble in water.  The films 
used for methanol treatment experiments were water-soluble films cast in ambient or 20 
oC temperature.  The solution was 50 % aqueous methanol solution. Immersion periods 
of 3, 6 and 10 minutes were applied.  After the films were placed in small beakers, first 
methanol and then water was added.  Films were rinsed with deionized water after 
treatment and left for drying at ambient temperature. 
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 5.2.1.2 Heat Treated SF Films 
 
For the heat-treated SF films, aqueous fibroin solution was used without 
concentrating.  The heat treatment is known to cause the β sheet transformation to 
occur.  The temperature of drying was 45 oC.  Relative humidity was not controlled and 
the samples were dried at the ventilated oven for one day.  The samples acquired some 
cracks attributed to the rapid drying.  There were also ordered crinkles, which were 
parallel to each other.  These samples were pretty brittle.  Heat-treated films were 
insoluble in water.  
 
5.2.2. 
5.2.3. 
Preparation of SF/HA Films 
 
Our goal was to form an insoluble biocompatible matrix which has adsorption 
capacity for positively charged drug molecules. The agent HA is a good candidate for 
this purpose.  10 % SF solution was used.  1 % HA solution was prepared by slowly 
adding HA to deionized water while stirring vigorously.  HA used in this study has a 
average molecular weight of 1.63 x 10-6 Dalton (Fluka).  The compositions of the 
fabricated membranes and their solubility are listed in Table 6.2.  The compositions of 
the fabricated films were designed to cover the full composition range. The pH values 
of the two blending agents were between 6-6.5.  The mixing of two agents was 
achieved by using magnetic stirrer in the casting container which is the Petri dish.   
 
SF Film Crosslinked with Glutaraldehyde 
 
In order to obtain SF films with good mechanical properties to be handled in the 
diffusion experiments, SF films were crosslinked with glutaraldehyde (GTA).  For this 
purpose, aqueous SF solution was used without further concentrating.  Films were cast 
on Petri dishes of 60 mm diameter to contain a total of 0.4 g fibroin and 0.4 ml of 25% 
GTA solution, and dried at ambient temperature for 3 days.  The thickness of the 
membranes was measured from SEM images.  They were 90-110 µm thick. 
 
For the preparation of drug loaded SFGTA films, same procedure was applied; 
with the exception that drug solution is mixed to the film during casting.  The amount 
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 of drug solution added was in the range of 40 to 150 µl.  In order to prepare the 
membrane for diffusion experiment, a round shaped membrane with a diameter of 13 
cm is cut from the mother film in the Petri dish.  The mother film is soaked with 10 ml 
of water for 10 minutes to make it flexible and prevent cracking during membrane 
cutting.  After the membrane is cut, it is rinsed with water and placed in the diffusion 
cell.  Some of the loaded drug can be dissolved during this stage. 
 
5.2.4. Freeze-Dried SF 
 
Freeze-dried films were prepared in order to obtain high surface area and 
insolubility. Aqueous fibroin solution was directly used without concentrating.  The 
freeze drier was operated between -45 and -50 oC.  The pressure was not controlled and 
randomly assigned by the device itself, changing around minus 250-300 mm Hg.  This 
form is denoted SFFD.  The product of the freeze drying was usually slightly soluble in 
water.  The freeze-dried sponge of fibroin was subjected to methanol treatment prior to 
adsorption experiments to ensure complete insolubility.  This is denoted SFFD-MT.  
The SEM images of samples were taken.  These were compared with the literature 
images [30].  The sponge samples for SEM were prepared with care since the sponge is 
very susceptible to the touch and can easily deform. 
 
There was another sponge produced in this way: first the SF solution was 
poured in a Petri dish of 60 mm diameter and then placed in the cryostat for freezing.  
Temperature reached steady-state at -35 oC and samples were frozen at this temperature 
for one hour.  Samples were stored at -18 oC in deep-freeze until they were freeze-dried 
at the same conditions listed above.   
 
5.3. Characterization of the Membranes 
 
The microstructures of the membranes were examined by SEM.  Results were 
extracted about the porosity, homogeneity, and surface morphology from images.  For 
crystallinity of the membrane, X-ray diffractometer (XRD) was used.  Fourier 
transform infrared spectroscopy (Ft-Ir) was used to understand the chemical interaction 
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 among SF and the blending agent HA [82].  Ft-Ir absorption bands for specific groups 
in the structure were analysed.   
 
5.3.1. 
5.3.2. 
Solubility Tests 
 
The solubility tests were performed by dipping the samples in deionized water 
and observing the state of the films visually for three days.  Some of the samples were 
directly subjected to the adsorption tests which counted as a solubility test, and the 
samples which were dissolved were quickly noted and eliminated from the adsorption 
tests.   
 
Analysis Methods 
 
The scanning electron microscope (SEM) images were taken from the surface 
and cross-section of the samples by Philips XL 30S FEG.  The images were used for 
assessment of porosity, homogeneity of blending agents (existence of separate phases), 
and configuration of the protein structure.  Measurement of thickness and pore size 
were made.  The X-ray diffraction (XRD) analysis gives us insight about the 
crystallinity of the samples.  XRD analysis was carried out by Philips X’Pert Pro.  This 
information can be interpreted by comparing the amorphous or crystalline samples, as 
well as any increase in crystallinity deserves attention.  It should be noted that the 3 
minute and 6 minute methanol treated films were ground to powder form for XRD 
analysis while 10 minute treated film was analysed directly.  In order to confirm the 
crystallization of fibroin in methanol, X-ray diffractograms of methanol treated films 
kept in aqueous methanol for increasing intervals of time were compared.  The Fourier 
transform infrared (Ft-Ir) spectroscopy is a powerful method to investigate the chemical 
bonds and interactions within a sample.  Samples in membrane form were subject to Ft-
Ir analysis by Shimadzu FTIR-8601. 
 
5.4. Adsorption Experiments 
 
Different samples prepared by different methods were tested for capability of 
adsorbing the model drug timolol maleate (TM).  Samples were placed in dilute 
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 solutions of TM changing between 2.5 and 5 mM.  The samples were cut from the 
films, freeze-dried sponges, raw silk and degummed silk.  The ultraviolet (UV) 
absorbance value is directly related to concentration of the adsorbed or released drug.  
The calibration curve for TM absorbance is given in Figure.A1 in Appendix A.  In this 
study absorbance value is used for the measurement of concentration.  It was required 
that the samples were insoluble in water since in case of presence of dissolved particles, 
the reliability of UV spectroscopy analysis would be reduced.  The samples were kept 
in the adsorption medium of timolol maleate solution for 3 days at the shaker-incubator 
at 35 oC and 100 rpm.  pH of solution was kept constant at 6.5 by phosphate buffer.  
Just prior to dipping in the timolol maleate solution, samples were soaked for a short 
time in buffer solution in order to let them absorb water.  This method makes it possible 
to exclude the sorption and consider only adsorption.  The   samples taken from the 
adsorption medium were diluted by deionized water or buffer solution to reduce the 
concentration to the range of analysis by UV.  Then the absorption at this concentration 
was corrected to actual value by multiplying with the dilution factor, subtracted from 
the original concentration of the stock solution.  Difference gave the amount adsorbed.  
Results were normalized to per gram basis to make a comparison between different 
samples and the literature results.  “Per gram” basis is more convenient than other 
options like “per unit area” basis since a comparable measurement of areas is not 
possible.   
 
5.5. Iontophoretic Experiments 
 
In order to test the performance of drug delivery from and through the 
membranes fabricated, the iontophoretic setup has been established.  The main parts of 
this setup is the diffusion cell, the Iomed iontophoretic drug delivery device as the 
power supply, the UV visible spectrophotometer with the flow cell installed, peristaltic 
pump, and the tubings, connections etc.  The schematic of the custom-made diffusion 
cell employed is given in Figure 5.3.  The design of the cell owes inspiration to Franz 
diffusion cells [83].  This cell consists of two polytetrafluoroethylene (PTFE) parts 
joined end to end and an o-ring in between, with the membrane fixed in the middle and 
sealed with two gaskets.  Silver/silverchloride electrodes were placed in the upper and 
lower compartments respectively.  The cathode (Ag) is on the upper side and anode 
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 (AgCl) on the lower side.  The design of the system enables in-situ analysis of the 
amount of drug delivered to the receptor solution.  This was achieved by employing a 
receptor solution chamber which is not very large.  Diameter is 13 mm which gives an 
active membrane area of 1.327 cm2.  The total volume of the receptor chamber has a 
volume of 4.2 ml.  This design ensures an undisturbed laminar flow in the receiver side.  
Vigorous mixing was not desirable since this would cripple the in-situ analysis of the 
drug delivery.   
 
The drug solution used in the experiments was the eye drop of timolol (Timosol 
by Bilim İlaç), which is a 0.5% aqueous solution, equivalent to 0.68 mg TM per mL of 
drug, or the stock solution of TM (Sigma) prepared again at 0.5%.  The volume of the 
injected drug solution was in the range of 40 µl to 1 ml.   
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 is sucked in from the PBS container.  The sample then flows through the receptor cell 
below the membrane and is sent to the flow-cell installed in the ultraviolet-visible 
spectrophotometer for analysis of TM concentration. Measured concentration data were 
recorded continuously at the computer. The sample was collected at the effluent 
container after leaving the flow-cell. 
 
Figure 5.4 Iontophoresis experiment set-up
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CHAPTER 6                                                                  
RESULTS 
6.1. Characterization of the Membranes 
 
6.1.1. Effect of Post Treatment on the Structure of Silk Fibroin 
 
The silk fibroin films cast from the aqueous solution were dried at varying 
conditions. The films cast at 20 oC and 45 percent relative humidity (RH) were soluble. 
Post-treatment with methanol was used to some of these membranes.  Heat treated films 
were prepared by casting and drying at 45 oC.  It is understood that unless an attempt 
was made to induce porosity in the structure, all fabricated SF films have dense 
structure. 
 
Insolubilization is required for loading drug on membranes and the delivery 
experiments in aqueous media.  Methanol treatment and heat treatment were used for 
this purpose on silk membranes.  All of the obtained insoluble matrices are listed in 
Table 6.1.  It was observed 3 minutes was long enough to make the films insoluble.  
Though both of the methanol (SFMT) and heat treated (SFHT) films possess crystalline 
structure, in literature grainy structure of SF films dried at high temperature is also 
mentioned [40].  This was also observed in this study.  Methanol and heat treated films 
were similar in physical appearance and their outcomes in analyses.  Some of heat 
treated films acquired cracks and wrinkles due to rapid drying.  Figure 6.1 compares the 
morphology of methanol treatment and heat treatment on SF.  The heat treated 
membranes also have a cross-section with varying porosity, which is attributed to the 
quick evaporation of the water content.  The methanol treated film was dense.  
 
It was observed that if the films were insoluble in water then they would not 
interact with water no matter how long they were exposed to water.  In case of soluble 
films, it was observed that the samples were dissolved at the very first minutes of 
exposure.  Some of the samples were dissolved partially.  XRD analysis is useful in 
explaining if the insolubility of any subject membrane was brought about by actually 
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 electrostatic interactions formed between or within the blended agents, or by 
configuration change which is dependent on drying conditions and factors like pH and 
ionic strength. 
Table 6.1 Insoluble Samples 
Sample Insolubilization achieved by 
Blend membrane w/ comp.  10% HA 90% 
SF 
Interaction justified by OH stretching 
Blend membrane w/ comp.  15% HA 85% 
SF 
Interaction justified by OH stretching 
Methanol treated SF film Configuration change to β pleated 
structure 
Heat treated SF film Configuration change to β pleated 
structure 
SF film cross-linked w/ glutaraldehyde Crosslinking 
Methanol treated SF freeze-dried sponge Configuration change to β pleated 
structure 
 
 
 
 
 
 
 
 
 
 
Figure 6.1 SEM image of cross-section of a) M
Magnification: 12000x. b) Heat treated SF (SFHT
 
Methanol treated SF membrane is dense 
depicted in Figure 6.1.a.  The heat treated memb
dense as other SF membranes.  The reason o
(a) )
 (bethanol treated SF (SFMT) membrane.  
) membrane.  Magnification: 5000x. 
with small pits on the cross-section as 
rane shown in Figure 6.1.b was not as 
f this could be explained by β-pleat 
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 formation and vaporization taking place simultaneously. The membranes acquired 
macropores of 1 to 4 µm. 
 
A high surface area is required to have a high drug adsorption capacity.  In order 
to increase surface area, freeze drying of the aqueous solution of fibroin was performed.  
A spongy structure was obtained.  Freeze-dried samples consist of a mixture random 
coil and β-pleated structure.  This was understood by partial solubility of the freeze-
dried sponge. Methanol treatment for 10 minutes in 50 % aqueous solution was applied 
in order to achieve insolubility.  Adsorption tests yielded comparable results with 
literature in terms of adsorbed drug per gram of material.  The freeze-dried sponge can 
be placed in between two layers of other membrane and used as a drug reservoir in 
iontophoresis.  As seen in Figure 6.2.a and Figure 6.2.b, the structure was porous with a 
high surface area.  Methanol treatment has turned the structure to a more porous form.  
 
 
 
 
 
 
 
 
 
 
F
M
f
(b)(b)(a) 
 (d)
 (c)igure 6.2 a) SEM image of freeze-dried SF sponge.  Magnification: 2000x. b) 
agnification: 650x.  c) After methanol treatment.  Magnification: 2000x. d) First 
rozen then freeze-dried SF.  Magnification: 250x.   
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The freeze dried SF sponge seen in Figure 6.2.c consists of regions with low and 
high porosity.  The samples have the well defined wall like structures and separate 
compartments. The samples could be compared with the literature samples of freeze 
dried SF by Li et al.[30], and the sheet-like structure was similar with the freeze-dried 
SF by Tsukada et al. [52].  Sample seen in Figure 6.2.d were first frozen and then 
freeze-dried.  Hence it had very low density and it was weak. 
 
To observe the effect of duration of metha l treatment, three identically formed 
films were treated in methanol and for 3, 6, a
results are given in Figure 6.3.  In Figure 6.3.a,
was not complete.  This film was also insolubl
order structure makes it insoluble.  This is in 
minutes is reported to be sufficient to make film
that insolubilization can be achieved by increase 
) 
 
\ 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 X-Ray diffractograms of SF films trea
MT 3 min) b) for 6 minutes (SF-MT 6 min) c) fo
treated SF film dried at 45 oC.  
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 The XRD of SF-MT 3 minute depicted in Figure 6.3.a is highly irregular and noisy.  In 
comparison, the SF-MT 6 minute (Figure 6.3.b) is more ordered and yields twice higher 
intensities. 
 
The crystalline peaks and increase in intensities are visible in at XRD result of 
SF-MT 10 minute Figure 6.3.c.  An interval of 10 minutes converts the structure to 
crystalline.  The sample was perfectly crystalline, yielding a peak at 16.85 2θ degree 
with an intensity of 471.  When X-ray results of SFMT 10 minute (Figure 6.3.c) and 
heat treated SF film dried at 45 oC (Figure 6.3.d) were compared, similar effects on the 
crystal structure of the films were observed.  The heat treated SF film yields an XRD 
pattern similar to the other crystalline structures.  The insolubility property and the 
crystal structure finding are consistent with the literature (47, 37, 40).   
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e 6.4 Ft-Ir spectra of a) silk film and b) methanol treated silk film. 
 been mentioned that the films cast from the aqueous solution are soluble and 
t of random coil and α structures.  In Chapter 3 it was stated that starting 
ntration and casting temperature is important for the structure of the fabricated 
 When casting temperature is below 40 oC, an aqueous solution yields an SF film 
-form and random coil, which is obviously soluble.  Treating in 50% aqueous 
nol for several minutes convert the silk fibroin to β pleated structure.  The 
uration change by methanol treatment can be detected by Ft-Ir spectra results of 
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 SF and SFMT films as given in Figure 6.4.  The characteristic peak of amide I and 
amide II bands are between 1620-1660 cm-1 and 1530-1540 cm-1 respectively [83, 82, 
85].  When SF and SFMT were compared, it was observed that the peaks attributed to 
both amide bonds were trimmed. That is to say, the absorbance peaks at the two amide 
bonds were lowered to the same intensity and became one broad peak. 
 
6.2. Formation of SF Film 
 
6.2.1. SF/HA Films 
 
The weight ratios of SF and HA and solubilities of films formed are given in 
Table 6.2. 
 
Table 6.2 Weight ratios of the two components in the polymer matrices.   
Hyaluronic acid Silk fibroin Solubility 
0 100 Soluble 
10 90 Insoluble 
15 85 Insoluble 
25 75 Soluble 
30 70 Soluble 
50  50 Soluble 
70  30 Soluble 
75  25 Soluble 
100 0 Soluble 
 
These films fall into two main categories: soluble and insoluble.  The solubility 
case might not necessarily mean that there was no interaction in the structure.  The 
stoichiometric balance amount of HA can cross-link with SF and excess HA would be 
free and dissolve in water.  However, there were no distinctive morphological 
differences between the soluble and insoluble films.  All were dense and for the most 
part non-porous.  All of the films below were around 10 µm thick.  When the two 
solutions were mixed, their mixture became white although both of the blending 
solutions were transparent.  Turbidity is a consequence of intense light scattering with 
colloidal dispersion [6].  Then our protein polysaccharide mixture of SF and HA was 
not perfectly homogeneous [86]. 
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 Similar results are reported in literature.  Kim et al. [86] have produced polyion 
complex composite membranes consisting of sodium alginate/chitosan.  The 
complexation occurs between the amino and carboxyl groups of the ionic polymers 
involved in this study.  It is stated that as the polyion complex formation proceeded, the 
O-H stretching peak at 3380 cm-1 became narrower, which is attributed to an increase in 
intermolecular interaction such as hydrogen bonding between sodium alginate and 
chitosan.  Coating achieved by electrostatic interactions between a cationic substance 
and HA was also mentioned earlier (Section 3.5) [77].  It is known that the presence of 
COOH groups in HA promote the formation of hydrogen bonds with components of the 
biological substrate in the body (mucoadhesiveness) [74].   
 
 It is also known that blending with other polymers like sodium alginate and 
chitosan can change conformation of silk [33].  The results for insoluble films could 
also be questioned in this aspect.  
 
6.3. Glutaraldehyde Cross-Linked SF Film 
 
The SFGTA film has very dense, non-porous and transparent structure.  The 
film looks virtually impenetrable in the SEM images.  SFGTA films have crystalline 
structure. 
6.4. Adsorption Experiments 
 
One aim of this study is to investigate the potential of SF drug reservoirs to be 
employed in iontophoretic delivery.  The second stage of this effort is to adsorb the 
drug molecules onto the films.  In order to investigate the TM adsorption capacity, 
membranes were placed in 10 ml aqueous solutions of timolol of various concentrations 
[79].  The pH of the solution was adjusted to 6.5-7.  Samples were equilibrated for 3 
days and after that, amount adsorbed was found from the difference in concentration of 
timolol in the initial and final solutions.  UV spectrophotometer was used to measure 
the TM concentration in the final solution.  The composition of the membrane that 
gives the maximum adsorption of timolol maleate was determined. 
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Figure 6.8 Ft-Ir spectra of a) HA film b) 10% HA, 90% SF soluble film c) 10% HA, 
90% SF insoluble film d) SF film 
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Figure 6.9 Results of adsorption experiment. Equilibrium concentrations. 
 
Adsorption tests were carried out for the two different freeze-dried sponges, raw 
silk, 10% HA insoluble film, and degummed silk.  All the samples adsorbed TM in the 
first day and released around 20 percent of the adsorbed amount.  This is a general trend 
observed in all the drug uptake experiments.  The average adsorbed amount around 0.2-
0.35 mmol per gram is depicted in Figure 6.9.  This amount was comparable with 
literature results where commercially available membranes were used [16], which was 
mentioned in section 2.2.4.  It was reported that TM had ionic interaction with carboxyl 
groups of the methacrylic acid [79].  Same interaction takes place in this study between 
timolol and carboxylic acid groups of hyaluronic acid. Blending the silk fibroin with 10 
% HA has increased drug loading capacity. 
 
6.5. Diffusion Experiments 
 
For the iontophoresis experiments silk fibroin membranes with good mechanical 
properties were needed.   Mechanical strength was required in order to handle the films 
in the diffusion cell.  For this purpose silk fibroin membrane crosslinked by 
glutaraldehyde were used in the experiments.   
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 6.5.1. Passive Diffusion Experiments 
 
The passive diffusion experiments were performed in the iontophoretic setup 
with the same buffer solutions and under the same conditions with exception that no 
current application was present. 
6.5.1.1 SFGTA Films 
6.5.1.1.1 Drug loaded SFGTA Films 
 
Figure 6.10 Passive drug delivery for SFGTA drug loaded film.  I=0. 
 
The passive diffusion results of the drug-loaded with 150 µl eye drop SFGTA 
membrane showed that the rate of diffusion was related to the concentration gradient.  
This membrane contained 0.236 millimoles of TM.  Flowrate was 4.87 ml/minute.  As 
the drug in the matrix was depleted rate slowed down as depicted in Figure 6.10.  It was 
observed that passive diffusion was unable to mobilize the drug molecules present in 
the membrane. 
6.5.1.1.2 Blank SFGTA Films 
 
When SFGTA membranes were used for passive delivery, they allowed 
diffusion of very low amounts of drug which was hardly measurable. 
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6.5.2. Active Diffusion Experiments 
 
In the active diffusion experiments, current was applied to the system after an 
initial passive diffusion interval of between 20and 30 minutes passed.  This passive 
diffusion interval serves as a basis and is visible in the absorbance results.  The current 
application was performed at three levels: 1, 2, and 4 milliamperes (mA).  When 
divided to the active membrane area of 1.327 cm2, these currents correspond to current 
densities of 0.75, 1.5, and 3 mA/ cm2 respectively.  The absorbance results of the active 
diffusion experiments at three current levels were compared with each other and the 
passive condition (I=0). 
 
In the following figures, (a) shows the absorption data for the delivery of drug 
and (b) shows the duration and magnitude of the current applied on the same time scale.  
Duration of current application is called a “pulse” in this text.  The applied dose in the 
iontophoretic delivery is the current level multiplied with the current application 
interval.  This dose was usually 80 mA minutes, which is the maximum amount 
deliverable at one run by Iomed power supply.  When current was 4 mA, this dose is 
given in 20 minutes.  When current is lowered, duration of current application extends.  
For instance, when current is reduced by half to 2 mA, duration doubles to 40 minutes.   
 
6.5.2.1 SFGTA Films 
6.5.2.1.1 Drug loaded SFGTA Films 
 
Drug loaded with 150 µl eye drop SFGTA membrane was washed with 
deionized water (DW) for 10 minutes prior to experiment.  The thicknesses of the films 
were 100 µm.  Flowrate was 4.5 ml/minute. The membrane contains 0.236 millimoles 
of TM.  There was an initial peak in drug absorption depicted in Figure 6.11.  This 
could be related to the initial washing of the membrane by the buffer flowing down in 
the receptor compartment.  After the gradual reduction in passive diffusion, the first 
pulse with I=1 mA was given for 40 minutes.  Sharp increase and following decrease 
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 was observed in drug release.  Then gradual reduction with a similar trend prevailed.  
The diffusion rate and course were similar with the passive diffusion but when the 
current was applied, a response was suddenly received.  Then the diffusion went back to 
the same track which was similar to passive diffusion. 
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Figure 6.11 a) Iontophoretic drug delivery for SFGTA drug loaded film.  b) Current 
application course with I=1 mA. 
 
It was understood that current application has mobilized some of the drug 
molecules which were adsorbed or trapped in the membrane.  This tells us that the 
current application has an enhancing effect on transport.  However, it was not possible 
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 to control the delivery in an on/off fashion.  Another membrane piece was cut from the 
same film and this time subjected to two different current levels of 2 and 4 mA 
respectively (Figure 6.12).  Flowrate was 4.3 ml/minute. The results of this experiment 
support the above suggestions.  Application of current at 2 mA level produced a quick 
response of diffusion increase.  When another current was applied at the higher value of 
4 mA, there was no or very slight response.  It is understood that in order to see a 
prominent increase in diffusion some accumulation of adsorbed or trapped drug 
molecules should take place.  The fact that the magnitude of the response is not closely 
related to the level of current applied support the suggestion of “enhancing/mobilizing” 
effect of current.  The drug molecules might have been cross-linked by GTA and 
therefore majority of them may be immobilized.  For Figure 6.11 and Figure 6.12, drug 
release was very low and these figures depict the poor performance of drug loaded 
membranes.  These figures report absorbance data obtained over duration of 
experiment. 
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Figure 6.12 a) Iontophoretic drug delivery for SFGTA drug loaded film.  b) Current 
application course of two current applications of I=2 and 4 mA. 
 
Figure 6.12 shows the drug delivery for SFGTA membrane loaded with 150 µl 
eye drop, having identical properties with membrane whose results were given in 
Figure 6.11.  The membrane contains 0.236 millimoles of TM.  It is understood that 
washing the drug loaded film prior to cutting does not release an amount of drug that 
will affect diffusion behaviour since this run produced an higher initial peak which 
indicates that drug in the membrane was not removed by washing. 
 
6.5.2.1.2 Blank SFGTA Films 
 
These films were produced identically with other SFGTA films.  The 
thicknesses of the films are between 90-110 µm.  Their behavior under current 
application and responsiveness has been investigated.  Drug loading was 1 ml from the 
stock solution which contains equivalent drug to the eye drop. This makes 1.572 
millimoles of TM.  The dose of the delivery was 80 mA minutes for all the three pulsed 
type experiments.  In all the experiments, there was a 20 minutes (1200 sec) of passive 
initial section.   
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Figure 6.13 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=4 mA a) Delivery of drug b) Current application course. 
 
In Figure 6.13, it is seen that after pulse was given at 4 mA, the released drug 
concentration showed a sharp increase.  Flowrate was 2.83 ml/minute.  After pulse 
ended, delivery level made a steep fall, but not to the initial value.  Delivery even 
increased for sometime and then decreased.  Around 80 minutes were given to the 
system to come to a stable course.  Then pulses were given in a regular fashion for 20 
minutes and 20 minutes was allowed to pass without current.  One cycle was a total of 
40 minutes.  All of these cycles produce eminent responses in the delivery.  As the drug 
in the receptor compartment was depleted, the peaks get smaller in magnitude and total 
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 area under the curves was similarly reduced.  A good control of delivery by current 
application was achieved. 
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Figure 6.14 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=2 mA a) Delivery of drug b) Current application course. 
 
The amount of released drug for 2 mA pulsed current application was given in 
Figure 6.14.  Flowrate was 3.37 ml/minute.  After pulse ends, delivery level continued 
to increase gradually.  After more than one hour, released drug concentration was 
nearly steady and then pulses were given in a regular fashion for 40 minutes and 
another 40 minutes was allowed to pass without current, making a cycle of 80 minutes.  
Again pulses produce visible responses in the delivery.  The peaks differed slightly in 
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 magnitude, yet total areas under the curves were approximately same.  This is 
reasonable considering the change in drug concentration in the receptor was slower 
compared to 4 mA case.  Current application could control amount of drug released. 
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Figure 6.15 Iontophoretic drug delivery experiment for SFGTA membrane.  Pulsed 
current application of I=1 mA a) Delivery of drug b) Current application course. 
 
The result of release experiment with 1 mA pulses is given in Figure 6.15.  
Flowrate was 3.09 ml/minute.  The system gave sluggish response with smaller 
amplitude compared to 4 and 2 mA cases.  There is a 20 minutes interval between the 
pulses.  This time pulses produce responses with increasing magnitude.  This is related 
to the gradual increase in the permeability of the membrane.   
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Three experiments at 4, 2, and 1 mA current levels are combined in Figure 6.16.  
It is suggested that there is a threshold value for the permeabilization of the membrane.  
When current was 4 mA, this threshold value was exceeded after first pulse was given.  
For 2 mA, threshold value was exceeded after two pulses.  Drug depletion does not 
have a considerable effect on diffusion rate in this case.  For the case when current was 
1 mA, threshold value was not exceeded during the course of the experiment and there 
was a gradual process of permeabilization.   
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Figure 6.16 Iontophoretic drug delivery for SFGTA membranes pulsed current 
application values of 1, 2, and 4 mA.   
 
In order to achieve controlled delivery of the drug in a pulsatile manner, current 
levels of 2 and 4 mA (current densities 1.5 and 3 mA/cm2) are sufficient.  Table 6.3 lists 
the amount of dosage application for three different current levels.  Dosage is obtained 
by multiplying current and application interval.  It was observed that the entire drug 
injected to the donor compartment passed to the receiver blank buffer solution for the 4 
mA case.  When current was lowered to 2 mA, 68 % delivery was obtained.  Lowering 
current level further to 1 mA resulted in a low drug release of 3.95 %.  2 mA is the 
threshold value for permeabilization of the membrane to take place and enable 
controlled drug release.  On the other hand, there is not a quantitative relation between 
 58
 dosage and delivery.  It is understood that current level governs the permeability of the 
membrane. 
 
Table 6.3 Dose applications and corresponding drug release for iontophoretic 
experiments 
Current 
level 
(mA) 
Total 
duration 
(minute) 
Total 
dose 
(mA 
minute)
Drug loading 
(millimoles) 
Drug 
delivered 
(millimoles) 
Percent 
delivered 
Percent 
retained 
4 180 720 1.47 1.528 103.94 0 
2 200 400 1.47 1.000 68 32 
1 260 260 1.47 0.058 3.95 96.15 
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Figure 6.17 X-Ray diffractogram of methanol treated (10 min) SF film after 
iontophoretic experiment.   
 
The XRD results show that the electric field applied in iontophoretic experiment 
converts the silk structure to a more crystalline state indicated by an increase in the 
intensity of peaks.  This could be observed when XRD results of methanol treated films 
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 before and after iontophoretic experiments, Figure 6.3 and Figure 6.17 are compared.  
Electric field application causes an increase of crystallinity in the structure.   
 
 
 
 
 
 
 
Figure 6.18 X-ray diffractograms of SFGTA film a) 
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CONCLUSIONS 
 
In this study, various forms of silk fibroin (SF) and SF with blending agents 
such as hyaluronic acid (HA) have been tested for their feasibility as a potential drug 
reservoir.  These were developed for use in iontophoretic transdermal drug delivery 
systems.  Different forms of silk and silk fibroin, such as raw silk, degummed SF, 
insolubilized freeze-dried SF, SF blended with HA were investigated for their 
adsorption capacity of timolol, which was used as the model drug.  The observed drug 
uptake capacities were close to those of commercial membranes in the market.  Fibroin, 
freeze-dried SF, and SF/HA films were compared to raw silk for drug loading capacity.  
Insolubilization of membranes by post treatment, manipulation of drying conditions, 
and blending with different agents were successfully achieved.  Configurational 
changes of fibroin protein and interactions between SF and HA were investigated by Ft-
Ir and XRD analyses.  The obtained insoluble membranes were investigated for drug 
delivery performance in a custom-made diffusion cell under passive diffusion and 
iontophoretic conditions.  It was demonstrated that the silk fibroin glutaraldehyde and 
methanol treated fibroin films could be successfully used for controlled drug delivery.  
There is a threshold value for permeabilization of the membrane. It was found that 
current densities 1.5 and 3 mA/cm2 were suitable to accomplish controlled delivery of 
the drug in a pulsatile manner.  The results of this study should be useful in controlled 
transdermal delivery of positively charged drug molecules.  
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 APPENDIX A 
Correlation between Timolol Maleate Concentration and UV 
Absorbance 
 
UV Analysis: Full spectrum analysis was performed for TM solution and it was 
observed TM had yielded absorption at 294 nm wavelength.  A calibration curve for 
analysis of TM at UV spectrophotometer (Shimadzu UV-1601) was obtained by 
analyzing known concentrations of TM at a wavelength of 294 nm.   
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Figure A1. Calibration curve for TM concentration at 294 nm 
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 APPENDIX B 
Formulas of Amino acids in Silk Fibroin 
 
The most abundant amino acids found in silk fibroin chain are given below. 
 
 
Glycine   Alanine   Serine 
N
O
    N
O
   N
O
O
 
 
With amino groups: 
Lysine    Arginine 
 
N
ON
        N
O
N
N
N
 
 
With a thiol group (containing sulphur): 
Cysteine 
N
O
S
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 APPENDIX C 
Structure of Alpha Helix 
 
In the α helix, every fourth AA forms an H-bond between a carbonyl- and an 
imino group.  Side chains point away from the helix. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 A3
  
APPENDIX D  
Smoothing by MathCAD 
 
Smoothing of data was performed using MathCAD 7 Professional by median 
smoothing method.  This method returns an m-element vector created by smoothing vy 
with running medians.  Span value is set to 7. 
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